Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular signal-regulated kinases (ERKs) are a family of serine/threonine protein kinases that play a central role in the mitogen-activated protein kinase (MAPK) signaling pathway. They are key intracellular signaling molecules involved in regulating diverse cellular processes, including proliferation, differentiation, survival, migration, and gene expression. Dysregulation of the Ras-Raf-MEK-ERK pathway is implicated in many cancers, and aberrant activity has been linked with chronic inflammation disorders. ERKs are activated by dual phosphorylation on threonine and tyrosine residues by MEK1/2, leading to dimerization, translocation to the nucleus, and phosphorylation of various transcription factors. They can also be activated by other mechanisms including Ca²⁺ influxes or G-protein-coupled receptor pathways.
Inhibition of ERK phosphorylation and activation, or inhibition of upstream kinases in the MAPK pathway such as B-Raf or MEK.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular signal-regulated kinase (ERK).